Skip to Main Content
Clinical Trials at Yale
YSM Home

INFORMATION FOR

Diseases of the Musculoskeletal System, Phase III

BMS 246 - Systemic Lupus Erythematosus (SLE)

What is the purpose of this trial?

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Lupus Research

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

  • Last Updated
    04/02/2024
  • Study HIC
    #2000033879

Contact Information

For more information about this study, including how to volunteer, contact Lupus Research